Literature DB >> 3276616

Simultaneous development of cells with large granular lymphocyte (LGL) morphology and natural killer (NK) cell lytic activity after bone marrow (BM) transplantation in mice.

O Silvennoinen1, M Hurme.   

Abstract

In the present study we investigated the development of natural killer (NK) cell lytic activity, and its correlation with the appearance of cells with large granular lymphocyte (LGL) morphology after bone marrow transplantation (BMT). NK activity was first found 7 days after bone marrow (BM) reconstitution, simultaneously with the appearance of the first LGLs. The number of LGLs, as well as the lytic activity, increased until Day 16 after BM reconstitution, after which they started to decrease, reaching the normal values of controls in 30 days. These early appearing LGLs differed somewhat from mature-type LGLs; they were larger, blast-like cells (found in the lower density fractions of Percoll gradient) and had a basophilic cytoplasma, in contrast to a pale cytoplasm in mature LGLs, but they expressed the asialo GM 1 (AGM 1) antigen like normal NK cells. Those NK cells that appeared first also tended to be lytically more effective than their mature counterparts. Taken together, these data suggest that the correlation between LGL morphology and NK lytic activity also holds true during the development of NK cells from their non-lytic precursors in the bone marrow.

Entities:  

Mesh:

Year:  1988        PMID: 3276616      PMCID: PMC1454701     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  33 in total

1.  Phenotypes of human natural killer cell populations detected with monoclonal antibodies.

Authors:  J M Zarling; K A Clouse; W E Biddison; P C Kung
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

2.  Fractionation, morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targets.

Authors:  T Timonen; E Saksela; A Ranki; P Häyry
Journal:  Cell Immunol       Date:  1979-11       Impact factor: 4.868

3.  "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype.

Authors:  R Kiessling; E Klein; H Wigzell
Journal:  Eur J Immunol       Date:  1975-02       Impact factor: 5.532

4.  Presence of T cell-associated surface antigens on murine NK cells.

Authors:  S B Pollack; M R Tam; R C Nowinski; S L Emmons
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

5.  Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells.

Authors:  C W Reynolds; T Timonen; R B Herberman
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

6.  Characterization of natural killer cells and their precursors in the murine bone marrow.

Authors:  O Silvennoinen; R Renkonen; M Hurme
Journal:  Cell Immunol       Date:  1986-08       Impact factor: 4.868

7.  Morphological characterization of a cell population responsible for natural killer activity.

Authors:  W Luini; D Boraschi; S Alberti; A Aleotti; A Tagliabue
Journal:  Immunology       Date:  1981-08       Impact factor: 7.397

8.  A glycolipid on the surface of mouse natural killer cells.

Authors:  M Kasai; M Iwamori; Y Nagai; K Okumura; T Tada
Journal:  Eur J Immunol       Date:  1980-03       Impact factor: 5.532

9.  Antigenic profile of murine natural killer cells.

Authors:  G C Koo; J B Jacobson; G J Hammerling; U Hammerling
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

10.  On the heterogeneity of murine natural killer cells.

Authors:  N Minato; L Reid; B R Bloom
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

View more
  1 in total

1.  Preferential homing of tumor-infiltrating lymphocytes in tumor-bearing mice.

Authors:  I H Ames; G M Gagne; A M Garcia; P A John; G M Scatorchia; R H Tomar; J G McAfee
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.